Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR26756
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Kohler, Christian; Carlstrom, Goran; Tangefjord, Stefan; Papavoine, Tineke; Lepisto, Matti; Edman, Karl; Akke, Mikael. "Backbone 1H, 13C, and 15N resonance assignments of the ligand binding domain of the human wildtype glucocorticoid receptor and the F602S mutant variant" Biomol. NMR Assign. 12, 263-268 (2018).
PubMed: 29667121
Assembly members:
Glucocorticoid_Receptor_Ligand_Binding_Domain, polymer, 250 residues, 29078.9 Da.
TIF-2_Nuclear_coactivator_2, polymer, 14 residues, 1705.9 Da.
entity_DEX, non-polymer, 392.461 Da.
entity_CPS, non-polymer, 614.877 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pET24a
Entity Sequences (FASTA):
Glucocorticoid_Receptor_Ligand_Binding_Domain: GTPTLVSLLEVIEPEVLYAG
YDSSVPDSYWRIMTTLNMLG
GRQVIAAVKWAKAIPGFRNL
HLDDQMTLLQYSWMFLMAFA
LGWRSYRQSSANLLCFAPDL
IINEQRMTLPCMYDQCKHML
YVSSELHRLQVSYEEYLCMK
TLLLLSSVPKDGLKSQELFD
EIRMTYIKELGKAIVKREGN
SSQNWQRFYQLTKLLDSMHE
VVENLLNYCFQTFLDKTMSI
EFPEMLAEIITNQIPKYSNG
NIKKLLFHQK
TIF-2_Nuclear_coactivator_2: KENALLRYLLDKDD
Data type | Count |
13C chemical shifts | 462 |
15N chemical shifts | 221 |
1H chemical shifts | 260 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | Glucocorticoid Receptor Ligand Binding Domain, 1 | 1 |
2 | Dexamethasone, 1 | 3 |
3 | TIF-2 Nuclear coactivator 2, 1 | 2 |
4 | CHAPS, 1 | 4 |
5 | Glucocorticoid Receptor Ligand Binding Domain, 2 | 1 |
6 | Dexamethasone, 2 | 3 |
7 | TIF-2 Nuclear coactivator 2, 2 | 2 |
8 | CHAPS, 2 | 4 |
Entity 1, Glucocorticoid Receptor Ligand Binding Domain, 1 250 residues - 29078.9 Da.
First Gly remains from purification tag
1 | GLY | THR | PRO | THR | LEU | VAL | SER | LEU | LEU | GLU | |
2 | VAL | ILE | GLU | PRO | GLU | VAL | LEU | TYR | ALA | GLY | |
3 | TYR | ASP | SER | SER | VAL | PRO | ASP | SER | TYR | TRP | |
4 | ARG | ILE | MET | THR | THR | LEU | ASN | MET | LEU | GLY | |
5 | GLY | ARG | GLN | VAL | ILE | ALA | ALA | VAL | LYS | TRP | |
6 | ALA | LYS | ALA | ILE | PRO | GLY | PHE | ARG | ASN | LEU | |
7 | HIS | LEU | ASP | ASP | GLN | MET | THR | LEU | LEU | GLN | |
8 | TYR | SER | TRP | MET | PHE | LEU | MET | ALA | PHE | ALA | |
9 | LEU | GLY | TRP | ARG | SER | TYR | ARG | GLN | SER | SER | |
10 | ALA | ASN | LEU | LEU | CYS | PHE | ALA | PRO | ASP | LEU | |
11 | ILE | ILE | ASN | GLU | GLN | ARG | MET | THR | LEU | PRO | |
12 | CYS | MET | TYR | ASP | GLN | CYS | LYS | HIS | MET | LEU | |
13 | TYR | VAL | SER | SER | GLU | LEU | HIS | ARG | LEU | GLN | |
14 | VAL | SER | TYR | GLU | GLU | TYR | LEU | CYS | MET | LYS | |
15 | THR | LEU | LEU | LEU | LEU | SER | SER | VAL | PRO | LYS | |
16 | ASP | GLY | LEU | LYS | SER | GLN | GLU | LEU | PHE | ASP | |
17 | GLU | ILE | ARG | MET | THR | TYR | ILE | LYS | GLU | LEU | |
18 | GLY | LYS | ALA | ILE | VAL | LYS | ARG | GLU | GLY | ASN | |
19 | SER | SER | GLN | ASN | TRP | GLN | ARG | PHE | TYR | GLN | |
20 | LEU | THR | LYS | LEU | LEU | ASP | SER | MET | HIS | GLU | |
21 | VAL | VAL | GLU | ASN | LEU | LEU | ASN | TYR | CYS | PHE | |
22 | GLN | THR | PHE | LEU | ASP | LYS | THR | MET | SER | ILE | |
23 | GLU | PHE | PRO | GLU | MET | LEU | ALA | GLU | ILE | ILE | |
24 | THR | ASN | GLN | ILE | PRO | LYS | TYR | SER | ASN | GLY | |
25 | ASN | ILE | LYS | LYS | LEU | LEU | PHE | HIS | GLN | LYS |
Entity 3, Dexamethasone, 1 - C22 H29 F O5 - 392.461 Da.
1 | DEX |
Entity 2, TIF-2 Nuclear coactivator 2, 1 14 residues - 1705.9 Da.
Nuclear coactivator 2
1 | LYS | GLU | ASN | ALA | LEU | LEU | ARG | TYR | LEU | LEU | ||||
2 | ASP | LYS | ASP | ASP |
Entity 4, CHAPS, 1 - C32 H58 N2 O7 S - 614.877 Da.
1 | CPS |
sample_1: Glucocorticoid Receptor Ligand Binding Domain, [U-13C; U-15N; U-2H], 0.3 mM; Dexamethasone 50 uM; CHAPS 1%; TIF-2 Nuclear coactivator 2 0.3 mM; potassium phosphate 20 mM; DTT 2 mM; sodium azide 0.02%
sample_2: Glucocorticoid Receptor Ligand Binding Domain, L-methionine (methyl-13C), 0.3 mM; Dexamethasone 50 uM; CHAPS 1%; TIF-2 Nuclear coactivator 2 0.3 mM; potassium phosphate 20 mM; DTT 2 mM; sodium azide 0.02%
sample_conditions_1: ionic strength: 0.12 M; pH: 7.5; pressure: 1 atm; temperature: 298 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
1H-15N TROSY | sample_1 | isotropic | sample_conditions_1 |
2D 1H-13C HSQC | sample_2 | isotropic | sample_conditions_1 |
3D HNCA | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_1 | isotropic | sample_conditions_1 |
3D HNCO | sample_1 | isotropic | sample_conditions_1 |
3D 1H-15N NOESY | sample_1 | isotropic | sample_conditions_1 |
TOPSPIN, Bruker Biospin - collection, processing
SPARKY, Goddard - chemical shift assignment
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks